Global Personalized Cell Therapy Market Growth (Status and Outlook) 2023-2029

February 2023 | 103 pages | ID: GD7436EC6704EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease

LPI (LP Information)' newest research report, the “Personalized Cell Therapy Industry Forecast” looks at past sales and reviews total world Personalized Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Personalized Cell Therapy sales for 2023 through 2029. With Personalized Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Personalized Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Personalized Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Personalized Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Personalized Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Personalized Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Personalized Cell Therapy.

The global Personalized Cell Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Personalized Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Personalized Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Personalized Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Personalized Cell Therapy players cover Novartis AG, Vericel Corporation, Bellicum Pharmaceuticals, MolMed SpA, Cytori Therapeutics Inc, Gilead Sciences, Inc, Celgene Corporation, Bluebird Bio and Aurora Biopharma Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Personalized Cell Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • By Cell Type
    • Hematopoietic Stem Cell
    • Skeletal Muscle Stem Cell
    • Mesenchymal Stem Cells
    • Lymphocytes
    • Others
  • By Technique
    • Platelet Transfusions
    • Bone Marrow Transplantation
    • Packed Red Cell Transfusions
    • Organ Transplantation
Segmentation by application
  • Cardiovascular Diseases
  • Neurological Disorders
  • Inflammatory Diseases
  • Diabetes
  • Cancer
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Novartis AG
  • Vericel Corporation
  • Bellicum Pharmaceuticals
  • MolMed SpA
  • Cytori Therapeutics Inc
  • Gilead Sciences, Inc
  • Celgene Corporation
  • Bluebird Bio
  • Aurora Biopharma Inc
  • Saneron CCEL Therapeutics?Inc
  • Kuur Therapeutics
  • MediGene AG
  • Sangamo Therapeutics
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Personalized Cell Therapy Market Size 2018-2029
  2.1.2 Personalized Cell Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Personalized Cell Therapy Segment by Type
  2.2.1 Hematopoietic Stem Cell
  2.2.2 Skeletal Muscle Stem Cell
  2.2.3 Mesenchymal Stem Cells
  2.2.4 Lymphocytes
  2.2.5 Others
2.3 Personalized Cell Therapy Market Size by Type
  2.3.1 Personalized Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
2.4 Personalized Cell Therapy Segment by Application
  2.4.1 Cardiovascular Diseases
  2.4.2 Neurological Disorders
  2.4.3 Inflammatory Diseases
  2.4.4 Diabetes
  2.4.5 Cancer
  2.4.6 Others
2.5 Personalized Cell Therapy Market Size by Application
  2.5.1 Personalized Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Personalized Cell Therapy Market Size Market Share by Application (2018-2023)

3 PERSONALIZED CELL THERAPY MARKET SIZE BY PLAYER

3.1 Personalized Cell Therapy Market Size Market Share by Players
  3.1.1 Global Personalized Cell Therapy Revenue by Players (2018-2023)
  3.1.2 Global Personalized Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Personalized Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PERSONALIZED CELL THERAPY BY REGIONS

4.1 Personalized Cell Therapy Market Size by Regions (2018-2023)
4.2 Americas Personalized Cell Therapy Market Size Growth (2018-2023)
4.3 APAC Personalized Cell Therapy Market Size Growth (2018-2023)
4.4 Europe Personalized Cell Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Personalized Cell Therapy Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Personalized Cell Therapy Market Size by Country (2018-2023)
5.2 Americas Personalized Cell Therapy Market Size by Type (2018-2023)
5.3 Americas Personalized Cell Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Personalized Cell Therapy Market Size by Region (2018-2023)
6.2 APAC Personalized Cell Therapy Market Size by Type (2018-2023)
6.3 APAC Personalized Cell Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Personalized Cell Therapy by Country (2018-2023)
7.2 Europe Personalized Cell Therapy Market Size by Type (2018-2023)
7.3 Europe Personalized Cell Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Personalized Cell Therapy by Region (2018-2023)
8.2 Middle East & Africa Personalized Cell Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Personalized Cell Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PERSONALIZED CELL THERAPY MARKET FORECAST

10.1 Global Personalized Cell Therapy Forecast by Regions (2024-2029)
  10.1.1 Global Personalized Cell Therapy Forecast by Regions (2024-2029)
  10.1.2 Americas Personalized Cell Therapy Forecast
  10.1.3 APAC Personalized Cell Therapy Forecast
  10.1.4 Europe Personalized Cell Therapy Forecast
  10.1.5 Middle East & Africa Personalized Cell Therapy Forecast
10.2 Americas Personalized Cell Therapy Forecast by Country (2024-2029)
  10.2.1 United States Personalized Cell Therapy Market Forecast
  10.2.2 Canada Personalized Cell Therapy Market Forecast
  10.2.3 Mexico Personalized Cell Therapy Market Forecast
  10.2.4 Brazil Personalized Cell Therapy Market Forecast
10.3 APAC Personalized Cell Therapy Forecast by Region (2024-2029)
  10.3.1 China Personalized Cell Therapy Market Forecast
  10.3.2 Japan Personalized Cell Therapy Market Forecast
  10.3.3 Korea Personalized Cell Therapy Market Forecast
  10.3.4 Southeast Asia Personalized Cell Therapy Market Forecast
  10.3.5 India Personalized Cell Therapy Market Forecast
  10.3.6 Australia Personalized Cell Therapy Market Forecast
10.4 Europe Personalized Cell Therapy Forecast by Country (2024-2029)
  10.4.1 Germany Personalized Cell Therapy Market Forecast
  10.4.2 France Personalized Cell Therapy Market Forecast
  10.4.3 UK Personalized Cell Therapy Market Forecast
  10.4.4 Italy Personalized Cell Therapy Market Forecast
  10.4.5 Russia Personalized Cell Therapy Market Forecast
10.5 Middle East & Africa Personalized Cell Therapy Forecast by Region (2024-2029)
  10.5.1 Egypt Personalized Cell Therapy Market Forecast
  10.5.2 South Africa Personalized Cell Therapy Market Forecast
  10.5.3 Israel Personalized Cell Therapy Market Forecast
  10.5.4 Turkey Personalized Cell Therapy Market Forecast
  10.5.5 GCC Countries Personalized Cell Therapy Market Forecast
10.6 Global Personalized Cell Therapy Forecast by Type (2024-2029)
10.7 Global Personalized Cell Therapy Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Novartis AG
  11.1.1 Novartis AG Company Information
  11.1.2 Novartis AG Personalized Cell Therapy Product Offered
  11.1.3 Novartis AG Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Novartis AG Main Business Overview
  11.1.5 Novartis AG Latest Developments
11.2 Vericel Corporation
  11.2.1 Vericel Corporation Company Information
  11.2.2 Vericel Corporation Personalized Cell Therapy Product Offered
  11.2.3 Vericel Corporation Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Vericel Corporation Main Business Overview
  11.2.5 Vericel Corporation Latest Developments
11.3 Bellicum Pharmaceuticals
  11.3.1 Bellicum Pharmaceuticals Company Information
  11.3.2 Bellicum Pharmaceuticals Personalized Cell Therapy Product Offered
  11.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Bellicum Pharmaceuticals Main Business Overview
  11.3.5 Bellicum Pharmaceuticals Latest Developments
11.4 MolMed SpA
  11.4.1 MolMed SpA Company Information
  11.4.2 MolMed SpA Personalized Cell Therapy Product Offered
  11.4.3 MolMed SpA Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 MolMed SpA Main Business Overview
  11.4.5 MolMed SpA Latest Developments
11.5 Cytori Therapeutics Inc
  11.5.1 Cytori Therapeutics Inc Company Information
  11.5.2 Cytori Therapeutics Inc Personalized Cell Therapy Product Offered
  11.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Cytori Therapeutics Inc Main Business Overview
  11.5.5 Cytori Therapeutics Inc Latest Developments
11.6 Gilead Sciences, Inc
  11.6.1 Gilead Sciences, Inc Company Information
  11.6.2 Gilead Sciences, Inc Personalized Cell Therapy Product Offered
  11.6.3 Gilead Sciences, Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Gilead Sciences, Inc Main Business Overview
  11.6.5 Gilead Sciences, Inc Latest Developments
11.7 Celgene Corporation
  11.7.1 Celgene Corporation Company Information
  11.7.2 Celgene Corporation Personalized Cell Therapy Product Offered
  11.7.3 Celgene Corporation Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Celgene Corporation Main Business Overview
  11.7.5 Celgene Corporation Latest Developments
11.8 Bluebird Bio
  11.8.1 Bluebird Bio Company Information
  11.8.2 Bluebird Bio Personalized Cell Therapy Product Offered
  11.8.3 Bluebird Bio Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Bluebird Bio Main Business Overview
  11.8.5 Bluebird Bio Latest Developments
11.9 Aurora Biopharma Inc
  11.9.1 Aurora Biopharma Inc Company Information
  11.9.2 Aurora Biopharma Inc Personalized Cell Therapy Product Offered
  11.9.3 Aurora Biopharma Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Aurora Biopharma Inc Main Business Overview
  11.9.5 Aurora Biopharma Inc Latest Developments
11.10 Saneron CCEL Therapeutics?Inc
  11.10.1 Saneron CCEL Therapeutics?Inc Company Information
  11.10.2 Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Product Offered
  11.10.3 Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Saneron CCEL Therapeutics?Inc Main Business Overview
  11.10.5 Saneron CCEL Therapeutics?Inc Latest Developments
11.11 Kuur Therapeutics
  11.11.1 Kuur Therapeutics Company Information
  11.11.2 Kuur Therapeutics Personalized Cell Therapy Product Offered
  11.11.3 Kuur Therapeutics Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Kuur Therapeutics Main Business Overview
  11.11.5 Kuur Therapeutics Latest Developments
11.12 MediGene AG
  11.12.1 MediGene AG Company Information
  11.12.2 MediGene AG Personalized Cell Therapy Product Offered
  11.12.3 MediGene AG Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 MediGene AG Main Business Overview
  11.12.5 MediGene AG Latest Developments
11.13 Sangamo Therapeutics
  11.13.1 Sangamo Therapeutics Company Information
  11.13.2 Sangamo Therapeutics Personalized Cell Therapy Product Offered
  11.13.3 Sangamo Therapeutics Personalized Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Sangamo Therapeutics Main Business Overview
  11.13.5 Sangamo Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Personalized Cell Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hematopoietic Stem Cell
Table 3. Major Players of Skeletal Muscle Stem Cell
Table 4. Major Players of Mesenchymal Stem Cells
Table 5. Major Players of Lymphocytes
Table 6. Major Players of Others
Table 7. Personalized Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Personalized Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
Table 10. Personalized Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Personalized Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Personalized Cell Therapy Market Size Market Share by Application (2018-2023)
Table 13. Global Personalized Cell Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Personalized Cell Therapy Revenue Market Share by Player (2018-2023)
Table 15. Personalized Cell Therapy Key Players Head office and Products Offered
Table 16. Personalized Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Personalized Cell Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Personalized Cell Therapy Market Size Market Share by Regions (2018-2023)
Table 21. Global Personalized Cell Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Personalized Cell Therapy Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Personalized Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Personalized Cell Therapy Market Size Market Share by Country (2018-2023)
Table 25. Americas Personalized Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
Table 27. Americas Personalized Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Personalized Cell Therapy Market Size Market Share by Application (2018-2023)
Table 29. APAC Personalized Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Personalized Cell Therapy Market Size Market Share by Region (2018-2023)
Table 31. APAC Personalized Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
Table 33. APAC Personalized Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Personalized Cell Therapy Market Size Market Share by Application (2018-2023)
Table 35. Europe Personalized Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Personalized Cell Therapy Market Size Market Share by Country (2018-2023)
Table 37. Europe Personalized Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
Table 39. Europe Personalized Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Personalized Cell Therapy Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Personalized Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Personalized Cell Therapy Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Personalized Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Personalized Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Personalized Cell Therapy Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Personalized Cell Therapy
Table 48. Key Market Challenges & Risks of Personalized Cell Therapy
Table 49. Key Industry Trends of Personalized Cell Therapy
Table 50. Global Personalized Cell Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Personalized Cell Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Personalized Cell Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Personalized Cell Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Novartis AG Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 55. Novartis AG Personalized Cell Therapy Product Offered
Table 56. Novartis AG Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Novartis AG Main Business
Table 58. Novartis AG Latest Developments
Table 59. Vericel Corporation Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 60. Vericel Corporation Personalized Cell Therapy Product Offered
Table 61. Vericel Corporation Main Business
Table 62. Vericel Corporation Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Vericel Corporation Latest Developments
Table 64. Bellicum Pharmaceuticals Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 65. Bellicum Pharmaceuticals Personalized Cell Therapy Product Offered
Table 66. Bellicum Pharmaceuticals Main Business
Table 67. Bellicum Pharmaceuticals Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Bellicum Pharmaceuticals Latest Developments
Table 69. MolMed SpA Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 70. MolMed SpA Personalized Cell Therapy Product Offered
Table 71. MolMed SpA Main Business
Table 72. MolMed SpA Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. MolMed SpA Latest Developments
Table 74. Cytori Therapeutics Inc Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 75. Cytori Therapeutics Inc Personalized Cell Therapy Product Offered
Table 76. Cytori Therapeutics Inc Main Business
Table 77. Cytori Therapeutics Inc Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Cytori Therapeutics Inc Latest Developments
Table 79. Gilead Sciences, Inc Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 80. Gilead Sciences, Inc Personalized Cell Therapy Product Offered
Table 81. Gilead Sciences, Inc Main Business
Table 82. Gilead Sciences, Inc Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Gilead Sciences, Inc Latest Developments
Table 84. Celgene Corporation Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 85. Celgene Corporation Personalized Cell Therapy Product Offered
Table 86. Celgene Corporation Main Business
Table 87. Celgene Corporation Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Celgene Corporation Latest Developments
Table 89. Bluebird Bio Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 90. Bluebird Bio Personalized Cell Therapy Product Offered
Table 91. Bluebird Bio Main Business
Table 92. Bluebird Bio Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Bluebird Bio Latest Developments
Table 94. Aurora Biopharma Inc Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 95. Aurora Biopharma Inc Personalized Cell Therapy Product Offered
Table 96. Aurora Biopharma Inc Main Business
Table 97. Aurora Biopharma Inc Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Aurora Biopharma Inc Latest Developments
Table 99. Saneron CCEL Therapeutics?Inc Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 100. Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Product Offered
Table 101. Saneron CCEL Therapeutics?Inc Main Business
Table 102. Saneron CCEL Therapeutics?Inc Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Saneron CCEL Therapeutics?Inc Latest Developments
Table 104. Kuur Therapeutics Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 105. Kuur Therapeutics Personalized Cell Therapy Product Offered
Table 106. Kuur Therapeutics Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Kuur Therapeutics Main Business
Table 108. Kuur Therapeutics Latest Developments
Table 109. MediGene AG Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 110. MediGene AG Personalized Cell Therapy Product Offered
Table 111. MediGene AG Main Business
Table 112. MediGene AG Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. MediGene AG Latest Developments
Table 114. Sangamo Therapeutics Details, Company Type, Personalized Cell Therapy Area Served and Its Competitors
Table 115. Sangamo Therapeutics Personalized Cell Therapy Product Offered
Table 116. Sangamo Therapeutics Main Business
Table 117. Sangamo Therapeutics Personalized Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Sangamo Therapeutics Latest Developments

LIST OF FIGURES

Figure 1. Personalized Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Cell Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Personalized Cell Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Personalized Cell Therapy Sales Market Share by Country/Region (2022)
Figure 8. Personalized Cell Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Personalized Cell Therapy Market Size Market Share by Type in 2022
Figure 10. Personalized Cell Therapy in Cardiovascular Diseases
Figure 11. Global Personalized Cell Therapy Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 12. Personalized Cell Therapy in Neurological Disorders
Figure 13. Global Personalized Cell Therapy Market: Neurological Disorders (2018-2023) & ($ Millions)
Figure 14. Personalized Cell Therapy in Inflammatory Diseases
Figure 15. Global Personalized Cell Therapy Market: Inflammatory Diseases (2018-2023) & ($ Millions)
Figure 16. Personalized Cell Therapy in Diabetes
Figure 17. Global Personalized Cell Therapy Market: Diabetes (2018-2023) & ($ Millions)
Figure 18. Personalized Cell Therapy in Cancer
Figure 19. Global Personalized Cell Therapy Market: Cancer (2018-2023) & ($ Millions)
Figure 20. Personalized Cell Therapy in Others
Figure 21. Global Personalized Cell Therapy Market: Others (2018-2023) & ($ Millions)
Figure 22. Global Personalized Cell Therapy Market Size Market Share by Application in 2022
Figure 23. Global Personalized Cell Therapy Revenue Market Share by Player in 2022
Figure 24. Global Personalized Cell Therapy Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Personalized Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 26. APAC Personalized Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Europe Personalized Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Personalized Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 29. Americas Personalized Cell Therapy Value Market Share by Country in 2022
Figure 30. United States Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Personalized Cell Therapy Market Size Market Share by Region in 2022
Figure 35. APAC Personalized Cell Therapy Market Size Market Share by Type in 2022
Figure 36. APAC Personalized Cell Therapy Market Size Market Share by Application in 2022
Figure 37. China Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Personalized Cell Therapy Market Size Market Share by Country in 2022
Figure 44. Europe Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Europe Personalized Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Germany Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Personalized Cell Therapy Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Personalized Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Personalized Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Personalized Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 60. APAC Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Europe Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 63. United States Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Canada Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 67. China Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Japan Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Korea Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 71. India Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Australia Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Germany Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 74. France Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 75. UK Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Italy Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Russia Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Spain Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 81. Israel Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Personalized Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 84. Global Personalized Cell Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Personalized Cell Therapy Market Size Market Share Forecast by Application (2024-2029)


More Publications